Azelis Group NV
Belgium · BE0974400328 · reports in EUR · Europe
The answers
From the annual report for the year to Dec 31, 2024. Each line says what it is based on.
- Is it growing?Fair
- Revenue +1.5% in the year to Dec 31, 2024, on the year before.
- Is it a good business?Fair
- It earned 6.3% on its shareholders' equity in the year to Dec 31, 2024.
- Is it safe?Good
- Equity is 51% of its assets, and operations brought in cash in the year.
- Is the price fair?n/a
- Not answered: no exchange publishes this company's price for free reuse, so there is no P/E here.
The year
Year to Dec 31, 2024, consolidated, in EUR.
revenue
operating margin
net profit
Year by year
As filed; an earlier year can differ from its own report when the company restated it.
| Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|
| Revenue | €2.8B | €4.1B | €4.2B | €4.2B |
| Operating profit | €208M | €388M | €387M | €386M |
| Net profit to shareholders | €68M | €213M | €178M | €181M |
| Earnings per share | €0.29 | €0.91 | €0.74 | €0.74 |
| Dividend per share | n/a | €0.03 | n/a | €0.22 |
| Cash from operations | €162M | €369M | €525M | €323M |
| Cash | €141M | €268M | €485M | €304M |
| Total assets | €4.0B | €5.0B | €5.6B | €5.8B |
| Equity | €2.3B | €2.4B | €2.7B | €2.9B |
What they do
In the company's own words, from the annual report.
distribution of specialty chemical products used in the Life Sciences (Personal Care, Home Care & Industrial Cleaning, Pharmaceuticals & Healthcare, Food & Nutrition, Animal Nutrition, and Agricultural & Environmental Solutions, and Flavors & Fragrances) and Industrial Chemicals industry (CASE, Advanced Materials & Additives, Lubricants & Metalworking Fluids, Electronics, Essentials and Fine Chemicals, and Textiles, Leather & Paper).
Source: the company’s annual financial report in ESEF, via filings.xbrl.org (XBRL International). Listed shares from ESMA’s FIRDS register; ESMA does not endorse this site. Ryufin computed the answers and ratios from the filed figures.